Anti-KAT1 / HAT1 antibody [EPR18661]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal KAT1 / HAT1 antibody. Suitable for IP, WB, IHC-P and reacts with Mouse, Human, Rat samples. Cited in 4 publications.
View Alternative Names
KAT1, HAT1, Histone acetyltransferase type B catalytic subunit, Histone acetyltransferase 1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling KAT1 / HAT1 with ab193097 at 1/1000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nuclear staining on human tonsil is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
KAT1 / HAT1 was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate with ab193097 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab193097 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HeLa whole cell lysate 10ug (Input).
Lane 2 : ab193097 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab193097 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-KAT1 / HAT1 antibody [EPR18661] (ab193097)
Predicted band size: 49 kDa
false
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
Immunohistochemical analysis of paraffin-embedded mouse colon tissue labeling KAT1 / HAT1 with ab193097 at 1/1000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nuclear staining on mouse colon is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
Immunohistochemical analysis of paraffin-embedded rat colon tissue labeling KAT1 / HAT1 with ab193097 at 1/1000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nuclear staining on rat colon is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
KAT1 / HAT1 was immunoprecipitated from 1mg of F9 (Mouse embryonic carcinoma cell line) whole cell lysate with ab193097 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab193097 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : F9 whole cell lysate 10ug (Input).
Lane 2 : ab193097 IP in F9 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab193097 in F9 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 1 second.
All lanes:
Immunoprecipitation - Anti-KAT1 / HAT1 antibody [EPR18661] (ab193097)
Predicted band size: 49 kDa
false
- WB
Supplier Data
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (ab193097) at 1/2000 dilution
Lane 1:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 3:
F9 (Mouse embryonic carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
LLC (Mouse lung carcinoma) whole cell lysate at 20 µg
Lane 5:
Mouse thymus lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 49 kDa
Observed band size: 45 kDa
false
Exposure time: 8s
- WB
Lab
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : KAT1 / HAT1 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : NIH3T3 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab193097 observed at 48 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab193097 was shown to specifically react with KAT1 / HAT1 when KAT1 / HAT1 knockout samples were used. Wild-type and KAT1 / HAT1 knockout samples were subjected to SDS-PAGE. ab193097 and ab8245 (loading control to GAPDH) were diluted to 1/1000 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (ab193097)
Predicted band size: 49 kDa
false
- WB
Supplier Data
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (ab193097) at 1/2000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Human fetal heart lysate at 10 µg
Lane 3:
Human fetal kidney lysate at 10 µg
Lane 4:
Human fetal spleen lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 49 kDa
Observed band size: 45 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (ab193097) at 1/2000 dilution
Lane 1:
C6 (Rat glial tumor cells) whole cell lysate at 10 µg
Lane 2:
RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 3:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg
Lane 4:
NIH/3T3 (Mouse embryonic fibroblast cells) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 49 kDa
Observed band size: 45 kDa
false
Exposure time: 5s
- WB
Unknown
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (AB193097)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KAT1 / HAT1 antibody [EPR18661] (ab193097)
Lane 1:
Mouse brain lysate at 10 µg
Lane 2:
Mouse heart lysate at 10 µg
Lane 3:
Mouse kidney lysate at 10 µg
Lane 4:
Rat brain lysate at 10 µg
Lane 5:
Rat heart lysate at 10 µg
Lane 6:
Rat kidney lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 49 kDa
Observed band size: 45 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-KAT1 / HAT1 antibody [EPR18661] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
KAT1 acts as a part of the histone acetyltransferase complex which plays a major role in regulating gene expression. By acetylating histone proteins it reduces chromatin compaction and allows gene transcription machinery access to DNA. This alteration can significantly influence cellular processes such as cell cycle regulation and DNA repair. As KAT1 interacts with several protein partners including other acetylation enzymes it serves as an important player in managing chromatin dynamics and maintaining genomic integrity.
Pathways
The role of KAT1 extends to involvement in the cell cycle and DNA damage repair pathways. In the cell cycle pathway KAT1 facilitates transcription required for progression through various phases of the cycle. In DNA damage response pathways KAT1 contributes to repairing DNA lesions by modifying chromatin to allow repair machinery access. It interacts with proteins such as p300 and CBP which are also acetyltransferases to modulate these pathways effectively and ensure cellular responses to DNA insults are adequate.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Journal of personalized medicine 15: PubMed40137423
2025
Applications
Unspecified application
Species
Unspecified reactive species
Current issues in molecular biology 46:3839-3865 PubMed38785507
2024
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 11:e495 PubMed34323404
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta. Gene regulatory mec 1861:962-970 PubMed30496041
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com